vs
Side-by-side financial comparison of LINKBANCORP, Inc. (LNKB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $46.0M, roughly 1.8× LINKBANCORP, Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -38.1%, a 44.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 7.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.6%).
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
LNKB vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $46.0M | $83.1M |
| Net Profit | $2.9M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 8.5% | -4.1% |
| Net Margin | 6.4% | -38.1% |
| Revenue YoY | 7.3% | 20.2% |
| Net Profit YoY | -61.2% | -27.9% |
| EPS (diluted) | $0.08 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $46.0M | $76.4M | ||
| Q3 25 | $44.8M | $83.3M | ||
| Q2 25 | $42.3M | $79.2M | ||
| Q1 25 | $53.4M | $69.2M | ||
| Q4 24 | $42.9M | $68.2M | ||
| Q3 24 | $42.9M | $58.4M | ||
| Q2 24 | $41.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $2.9M | $-29.8M | ||
| Q3 25 | $7.8M | $-21.4M | ||
| Q2 25 | $7.4M | $-19.6M | ||
| Q1 25 | $15.3M | $-24.7M | ||
| Q4 24 | $7.6M | $-18.9M | ||
| Q3 24 | $7.1M | $-21.0M | ||
| Q2 24 | $5.8M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 8.5% | -40.6% | ||
| Q3 25 | 22.3% | -27.8% | ||
| Q2 25 | 22.4% | -28.0% | ||
| Q1 25 | 36.0% | -39.7% | ||
| Q4 24 | 22.6% | -28.9% | ||
| Q3 24 | 21.3% | -38.4% | ||
| Q2 24 | 18.0% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 6.4% | -39.1% | ||
| Q3 25 | 17.5% | -25.7% | ||
| Q2 25 | 17.5% | -24.7% | ||
| Q1 25 | 28.7% | -35.8% | ||
| Q4 24 | 17.7% | -27.6% | ||
| Q3 24 | 16.5% | -35.9% | ||
| Q2 24 | 14.1% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.08 | $-0.54 | ||
| Q3 25 | $0.21 | $-0.38 | ||
| Q2 25 | $0.20 | $-0.35 | ||
| Q1 25 | $0.41 | $-0.45 | ||
| Q4 24 | $0.21 | $-0.34 | ||
| Q3 24 | $0.19 | $-0.40 | ||
| Q2 24 | $0.16 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.3M | $245.6M |
| Total DebtLower is stronger | $177.3M | $51.7M |
| Stockholders' EquityBook value | $306.4M | $347.7M |
| Total Assets | $3.1B | $487.1M |
| Debt / EquityLower = less leverage | 0.58× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $52.3M | $286.5M | ||
| Q3 25 | $194.2M | $294.3M | ||
| Q2 25 | $155.1M | $302.7M | ||
| Q1 25 | $220.2M | $316.2M | ||
| Q4 24 | $166.1M | $333.7M | ||
| Q3 24 | $191.2M | $196.8M | ||
| Q2 24 | $181.7M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $177.3M | $51.6M | ||
| Q3 25 | $102.3M | $51.6M | ||
| Q2 25 | $102.3M | $51.5M | ||
| Q1 25 | $102.7M | $51.5M | ||
| Q4 24 | $112.5M | $51.5M | ||
| Q3 24 | $102.4M | $51.4M | ||
| Q2 24 | $102.3M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $306.4M | $365.9M | ||
| Q3 25 | $305.5M | $380.3M | ||
| Q2 25 | $298.0M | $385.8M | ||
| Q1 25 | $294.1M | $389.2M | ||
| Q4 24 | $280.2M | $402.2M | ||
| Q3 24 | $277.4M | $241.2M | ||
| Q2 24 | $271.4M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $3.1B | $508.1M | ||
| Q3 25 | $3.1B | $511.5M | ||
| Q2 25 | $2.9B | $513.1M | ||
| Q1 25 | $2.9B | $519.4M | ||
| Q4 24 | $2.9B | $534.0M | ||
| Q3 24 | $2.9B | $374.1M | ||
| Q2 24 | $2.9B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.58× | 0.14× | ||
| Q3 25 | 0.33× | 0.14× | ||
| Q2 25 | 0.34× | 0.13× | ||
| Q1 25 | 0.35× | 0.13× | ||
| Q4 24 | 0.40× | 0.13× | ||
| Q3 24 | 0.37× | 0.21× | ||
| Q2 24 | 0.38× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | — |
| Free Cash FlowOCF − Capex | $23.8M | — |
| FCF MarginFCF / Revenue | 51.7% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 8.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $25.3M | $-10.3M | ||
| Q3 25 | $23.6M | $-6.6M | ||
| Q2 25 | $6.3M | $-15.0M | ||
| Q1 25 | $2.6M | $-17.0M | ||
| Q4 24 | $25.4M | $-32.4M | ||
| Q3 24 | $14.0M | $-18.8M | ||
| Q2 24 | $6.4M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $23.8M | $-12.2M | ||
| Q3 25 | $23.2M | $-9.5M | ||
| Q2 25 | $6.1M | $-17.8M | ||
| Q1 25 | $2.2M | $-18.8M | ||
| Q4 24 | $22.6M | $-33.6M | ||
| Q3 24 | $13.1M | $-19.0M | ||
| Q2 24 | $6.3M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 51.7% | -15.9% | ||
| Q3 25 | 51.8% | -11.4% | ||
| Q2 25 | 14.5% | -22.5% | ||
| Q1 25 | 4.2% | -27.2% | ||
| Q4 24 | 52.6% | -49.2% | ||
| Q3 24 | 30.5% | -32.6% | ||
| Q2 24 | 15.3% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 2.4% | ||
| Q3 25 | 0.8% | 3.4% | ||
| Q2 25 | 0.4% | 3.5% | ||
| Q1 25 | 0.7% | 2.7% | ||
| Q4 24 | 6.7% | 1.7% | ||
| Q3 24 | 2.1% | 0.4% | ||
| Q2 24 | 0.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.59× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | 0.85× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 3.35× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 1.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LNKB
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |